
Hematology Month in Review: May 2025
May was a slow month for hematology at HCPLive, with relative silence from the FDA and an even spread of trial successes and failures. NovelMed’s Ruxoprubart, a novel complement-targeting immunotherapy, showed efficacy for treating paroxysmal nocturnal …